Ted Yednock - 16 Feb 2024 Form 4 Insider Report for Annexon, Inc. (ANNX)

Signature
/s/ Jennifer Lew, Attorney-in-Fact
Issuer symbol
ANNX
Transactions as of
16 Feb 2024
Transactions value $
-$14,348
Form type
4
Filing time
21 Feb 2024, 16:31:47 UTC
Previous filing
14 Feb 2024
Next filing
17 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANNX Common Stock Award $0 +39K +108.11% $0.00 75.1K 16 Feb 2024 Direct F1
transaction ANNX Common Stock Sale -$14.3K -2.6K -3.47% $5.51 72.5K 20 Feb 2024 Direct F2, F3
holding ANNX Common Stock 21K 16 Feb 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Award $0 +160K $0.00 160K 16 Feb 2024 Common Stock 160K $5.13 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025.
F2 The shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.
F3 This transaction was executed in multiple trades in prices ranging from $5.34 to $5.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.